Correlation Between Cadrenal Therapeutics, and Trevi Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Trevi Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Trevi Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Trevi Therapeutics, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Trevi Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Trevi Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Trevi Therapeutics.
Diversification Opportunities for Cadrenal Therapeutics, and Trevi Therapeutics
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cadrenal and Trevi is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Trevi Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Trevi Therapeutics and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Trevi Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Trevi Therapeutics has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Trevi Therapeutics go up and down completely randomly.
Pair Corralation between Cadrenal Therapeutics, and Trevi Therapeutics
Given the investment horizon of 90 days Cadrenal Therapeutics, Common is expected to generate 1.74 times more return on investment than Trevi Therapeutics. However, Cadrenal Therapeutics, is 1.74 times more volatile than Trevi Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Trevi Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 1,509 in Cadrenal Therapeutics, Common on August 29, 2024 and sell it today you would lose (138.00) from holding Cadrenal Therapeutics, Common or give up 9.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cadrenal Therapeutics, Common vs. Trevi Therapeutics
Performance |
| Timeline |
| Cadrenal Therapeutics, |
| Trevi Therapeutics |
Cadrenal Therapeutics, and Trevi Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cadrenal Therapeutics, and Trevi Therapeutics
The main advantage of trading using opposite Cadrenal Therapeutics, and Trevi Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Trevi Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Trevi Therapeutics will offset losses from the drop in Trevi Therapeutics' long position.| Cadrenal Therapeutics, vs. Eliem Therapeutics | Cadrenal Therapeutics, vs. Scpharmaceuticals | Cadrenal Therapeutics, vs. Milestone Pharmaceuticals | Cadrenal Therapeutics, vs. Seres Therapeutics |
| Trevi Therapeutics vs. Cue Biopharma | Trevi Therapeutics vs. AN2 Therapeutics | Trevi Therapeutics vs. Bioatla | Trevi Therapeutics vs. Spero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |